Faktor Vii

Human Coagulation Factor VII is a recombinant protein used to manage bleeding episodes in certain medical conditions. This intravenous medication supports blood clotting and is often used in hemophilia treatment.

Human Coagulation Factor VII is primarily used to control bleeding in individuals with hemophilia or other clotting disorders. It works by replacing the missing clotting factor in the blood, helping to form clots and stop bleeding. This medication is often administered intravenously to provide rapid relief during bleeding episodes.

Common effects of Human Coagulation Factor VII may include localized reactions at the injection site, such as redness or swelling. Some individuals might experience mild flu-like symptoms, including fever or chills. These effects are generally temporary and subside as the body adjusts to the medication.

Human Coagulation Factor VII should be used under medical supervision. It is important to inform healthcare providers about any allergies or pre-existing conditions before administration. Proper storage and handling are crucial to maintain the effectiveness of the medication.

Human Coagulation Factor VII may interact with other medications that affect blood clotting. It is advisable to consult a healthcare provider before combining it with other treatments. Alcohol and certain foods may also influence its effectiveness, so it is best to follow medical advice regarding lifestyle adjustments.